Micofenolato De Mofetil Tecnigen

Mycophenolate Mofetil, the active ingredient in Micofenolato De Mofetil Tecnigen, is an antimetabolite immunosuppressant presented as an oral formulation for oral use. It is employed to prevent graft rejection in recipients of solid organ transplants.

GNH USA supplies Micofenolato De Mofetil Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers. Products are shipped with temperature‑controlled packaging where required and tracked through a secure logistics network.

Mycophenolate Mofetil is used as an immunosuppressive agent to reduce immune‑mediated rejection in organ transplantation.

- Kidney transplantation: helps maintain graft function by inhibiting lymphocyte proliferation. - Heart transplantation: reduces incidence of acute rejection episodes. - Liver transplantation: supports long‑term graft survival through immune suppression.

Mycophenolate Mofetil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Abdominal pain - Upper respiratory tract infection

Serious or Rare Side Effects: - Leukopenia or neutropenia - Severe infections (including opportunistic pathogens) - Hepatotoxicity - Malignancy, such as lymphoproliferative disorders

When prescribing Mycophenolate Mofetil, clinicians should observe several precautionary measures.

- Monitor blood counts: perform regular CBC to detect leukopenia or anemia. - Assess renal function: adjust dosing in patients with impaired kidney function. - Screen for infections: evaluate for active or latent infections before initiation. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25°C, protect from moisture in original packaging.

Mycophenolate Mofetil interacts with several drugs that may alter its efficacy or safety profile.

Major Interactions (Avoid): - Cyclosporine: increased mycophenolate exposure; monitor levels. - Tacrolimus: additive immunosuppression; heightened infection risk. - Live vaccines: may cause disease due to immunosuppression.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce absorption; separate dosing. - Azathioprine: combined bone marrow suppression; monitor blood counts.